About 1 in 7 new mothers in the US experiences postpartum depression, making it one of the most common complications of childbirth. The condition is not “baby blues” — those mild mood changes affect up to 80% of new mothers and resolve within two weeks. Postpartum depression is a serious mood disorder requiring treatment, and untreated it can affect maternal health, infant bonding, and child development. Encouragingly, the past few years have seen substantial advances, including the first FDA-approved oral medication specifically for the condition.
This guide covers what postpartum depression actually involves, how it differs from baby blues and postpartum psychosis, and which treatments have the strongest evidence. For more context, see our medical conditions resource hub.
When to seek emergency care: If you or someone you know is having thoughts of harming the baby, hallucinations, severe confusion, or thoughts of suicide, call or text 988 (Suicide & Crisis Lifeline) or go to the nearest emergency room. Postpartum psychosis is a psychiatric emergency requiring immediate intervention.
What Postpartum Depression Is
Postpartum depression is a major depressive episode with onset during pregnancy or within four weeks after delivery, though clinically the term is applied to depression occurring up to a year postpartum. The DSM-5 uses the broader “peripartum onset” specifier. Symptoms parallel those of major depressive disorder: low mood, loss of interest, sleep and appetite changes, fatigue, guilt, difficulty concentrating, and suicidal thoughts.
According to the CDC, roughly 13% of US mothers report postpartum depressive symptoms. Rates vary by state, race, age, and access to care. Approximately 50% of cases go undiagnosed, partly because symptoms can be mistaken for normal new-parent fatigue.
Baby Blues vs Postpartum Depression vs Postpartum Psychosis
Baby blues affect 50-80% of new mothers and involve mild mood swings, tearfulness, irritability, and sleep difficulties peaking around day 3-5 postpartum and resolving within two weeks. No treatment is required beyond support and rest.
Postpartum depression persists beyond two weeks, is more severe, and requires treatment. Symptoms include profound sadness or numbness, intense guilt about parenting, intrusive thoughts about harm coming to the baby (typically without intent), inability to bond with the infant, and impaired functioning.
Postpartum psychosis is a rare but severe condition affecting 1-2 per 1,000 births, typically presenting within the first two weeks after delivery. Symptoms include hallucinations, delusions, severe confusion, and rapid mood changes. Risk of harm to mother or infant is significant. This is a psychiatric emergency requiring inpatient treatment.
Symptoms Specific to Postpartum Depression
Beyond standard depressive symptoms, postpartum depression often features unique elements. Intrusive thoughts about accidentally or intentionally harming the baby occur in roughly half of cases — these are typically ego-dystonic (distressing and unwanted) rather than reflecting actual intent, and they often resemble OCD symptoms. Up to 11% of postpartum women develop OCD-like symptoms.
Difficulty bonding with the infant, feeling like a “bad mother,” and inability to feel pleasure even from positive interactions with the baby are common. Anxiety frequently dominates the picture — postpartum anxiety can occur with or without depression and includes excessive worry about infant health, sleep, feeding, and safety.
Causes and Risk Factors
Postpartum depression results from a combination of hormonal, biological, psychological, and social factors. The dramatic drop in estrogen and progesterone after delivery, sleep deprivation, thyroid dysfunction (postpartum thyroiditis affects 5-10% of mothers), and changes in stress hormone systems all contribute. Per Mayo Clinic, history of depression, anxiety, or bipolar disorder is the strongest predictor.
Other risk factors include difficult pregnancy or birth, NICU admission, breastfeeding difficulties, lack of social support, financial stress, partner relationship problems, history of trauma, and unintended pregnancy. Adolescent mothers and mothers with multiple births face elevated risk.
Screening and Diagnosis
The Edinburgh Postnatal Depression Scale (EPDS) is the standard screening tool, with scores of 10 or above warranting follow-up evaluation. Per ACOG and USPSTF guidelines, all pregnant and postpartum women should be screened at multiple points during prenatal and postpartum care. Despite recommendations, screening rates vary widely, and many cases still go unrecognized.
A thorough evaluation rules out medical contributors. Postpartum thyroiditis is particularly important — it commonly presents 4-12 months after delivery and can produce mood symptoms easily mistaken for postpartum depression. Anemia, vitamin D deficiency, and sleep disorders should also be considered.
Treatment Options
Mild to moderate cases often respond to psychotherapy alone. Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) both have strong evidence in postpartum depression, with IPT particularly suited to the relational changes of new parenthood. Response rates run 50-70% with structured therapy.
For moderate to severe cases, medication is often added. SSRIs (sertraline is most commonly used because of low transfer to breast milk) are first-line. Sertraline, escitalopram, and fluoxetine all have data supporting safety during breastfeeding. Per Cleveland Clinic, the risk-benefit calculation generally favors treatment of moderate to severe symptoms even during breastfeeding.
Newer Medications: Brexanolone and Zuranolone
The past few years have introduced two FDA-approved treatments specifically for postpartum depression. Brexanolone (Zulresso), approved in 2019, is an IV infusion given over 60 hours in a monitored setting. It produces rapid improvement, often within days, but requires inpatient or specialized outpatient administration and costs $34,000+ per course.
Zuranolone (Zurzuvae), approved in 2023, is a once-daily oral medication taken for 14 days. Clinical trials show rapid improvement, often within 3 days, with response sustained for weeks after the course ends. Costs run $15,000-$16,000 per course; insurance coverage varies. Both medications work on GABA-A receptors via allopregnanolone-related mechanisms, distinct from SSRIs.
Lifestyle and Support
Sleep is critical. New mothers commonly accumulate severe sleep deprivation, which substantially worsens mood. Strategies that allow longer continuous sleep — partner-shared night feedings, expressed milk, formula supplementation — meaningfully reduce depression risk. Per research, even one 4-hour stretch of continuous sleep produces measurable improvement.
Social support is among the strongest protective factors. Peer support groups (in-person or online), partner involvement, and practical help with household tasks all matter. Postpartum doulas, lactation consultants, and home visiting programs provide structured support in some areas.
When to See a Doctor
Symptoms persisting beyond two weeks, worsening rather than improving, accompanied by inability to care for self or baby, or with any thoughts of self-harm or harm to the baby warrant prompt evaluation. OB-GYNs, primary care physicians, and pediatricians (who see the family more frequently in the first year) all have roles in identifying and initiating treatment.
Generic SSRIs cost $4-$15 per month. Therapy ranges from $80-$250 per session out-of-pocket, and most insurance plans cover behavioral health. Postpartum Support International (1-800-944-4773) offers a helpline, support groups, and provider directory. Some telehealth platforms specialize in maternal mental health.
Frequently Asked Questions
How long does postpartum depression last?
Without treatment, episodes typically last several months to a year. With treatment, most patients see meaningful improvement within 4-8 weeks of starting therapy or medication. Some women develop chronic depression if untreated, and risk of recurrence in future pregnancies is substantial.
Can fathers get postpartum depression?
Yes. Roughly 8-10% of new fathers develop depression during the postpartum period. Risk factors include maternal depression, sleep deprivation, financial stress, and history of mood disorder. Paternal postpartum depression is underrecognized and affects child development outcomes.
Is it safe to take antidepressants while breastfeeding?
Several SSRIs, particularly sertraline, transfer to breast milk in very small amounts and have substantial safety data. Untreated maternal depression carries its own risks for infant development. Most clinicians and lactation specialists view treated depression with safer SSRIs as preferable to untreated illness, but the decision is individualized.
Can postpartum depression affect the baby?
Untreated maternal depression is associated with effects on infant attachment, language development, and emotional regulation. The good news is that treating maternal depression substantially mitigates these effects. Recovery is good for the mother and the child.
The Bottom Line
Postpartum depression is common, treatable, and not a reflection of being a bad parent. Effective treatments range from therapy alone for milder cases to combinations of therapy, SSRIs, and newer rapid-acting options for severe cases. The earlier treatment starts, the better the outcome — for the mother, the partner, and the baby. If symptoms persist beyond the first two weeks postpartum, an evaluation with an OB-GYN, primary care physician, or maternal mental health specialist is a valuable next step.